NDC 55150-365

Amphotericin B

Amphotericin B

Amphotericin B is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Eugia Us Llc. The primary component is Amphotericin B.

Product ID55150-365_6f24975c-5191-4fc2-a8da-e57358f8e154
NDC55150-365
Product TypeHuman Prescription Drug
Proprietary NameAmphotericin B
Generic NameAmphotericin B
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-11-17
Marketing CategoryANDA /
Application NumberANDA214010
Labeler NameEugia US LLC
Substance NameAMPHOTERICIN B
Active Ingredient Strength50 mg/12.5mL
Pharm ClassesLipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55150-365-01

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-365-01) > 12.5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-11-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Amphotericin B" or generic name "Amphotericin B"

NDCBrand NameGeneric Name
39822-1055Amphotericin BAmphotericin B
55150-365Amphotericin BAmphotericin B
62756-233Amphotericin BAmphotericin B
0469-3051AmBisomeamphotericin B

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.